African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 5, May 2025 | pp. 078–088

DOI: 10.46882/AJIDR/148757

Article Type: Research Article

Title: Diagnostic utility of urine lipoarabinomannan lateral flow assay for disseminated tuberculosis in hospitalized HIV patients

Names of Authors: Thandeka Zulu¹*, Kenji Watanabe², Sofia Alvarez³

Authors’ Affiliations: ¹Department of Internal Medicine, University of Cape Town, Cape Town, South Africa. ²Department of Respiratory Medicine, Kyoto University, Kyoto, Japan. ³Department of Infectious Diseases, National Autonomous University of Mexico, Mexico City, Mexico.

Abstract: Disseminated tuberculosis carries high early mortality among hospitalized people living with advanced HIV due to diagnostic delays. We evaluated the sensitivity, specificity, and mortality impact of point-of-care urine lipoarabinomannan testing among severely immunocompromised inpatients. Urine and sputum samples from 265 HIV-positive adults with CD4 counts below 200 cells per microliter were tested using lateral flow lipoarabinomannan assay and mycobacterial culture. Urine testing achieved a sensitivity of 64.5 percent and specificity of 93.8 percent, rising to 76.2 percent sensitivity in patients with CD4 counts under 100 cells per microliter. Same-day assay positivity enabled rapid antituberculosis treatment initiation within 24 hours. Routine urine lipoarabinomannan screening should be integrated into inpatient HIV admission protocols.

Keywords: Disseminated tuberculosis, HIV co-infection, Urine lipoarabinomannan, Point-of-care testing, Inpatient mortality

Citation: Zulu T, Watanabe K, Alvarez S (2025). Diagnostic utility of urine lipoarabinomannan lateral flow assay for disseminated tuberculosis in hospitalized HIV patients. African Journal of Infectious Diseases Research, 12(5): 078–088. DOI: 10.46882/AJIDR/148757

Manuscript Timeline: Received: March 30, 2025; Revised: May 02, 2025; Accepted: May 14, 2025; Published: May 22, 2025